Fritextsökning
Innehållstyper
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Enjoy Stockholm - the capital of Scandinavia
Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
New type of stem cell discovered
The earlier view of the scientific community was that melanocytes, the pigment cells, derive from the spinal cord during the early fetal period and then move ov...
-
Definite answer with new cancerous gene
A newly discovered cancer gene is enabling the diagnosis of adenoid cystic caranoima using a genetic test.
-
Analytisk kemi nytt ben för Recipharm
CDMO Recipharm lanserar en fristående tjänst inom analytisk kemi.
-
Ny glaskeram för tandlagning
Forskare på Ångströmlaboratoriet vid Uppsala universitet har tagit fram glaskeramer lämpliga som tandlagningsmaterial, som är tre gånger starkare än befintliga.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Norwegian entrance in EU technology network
The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.
-
Studie: Så länge klarar sig corona på olika ytor
Klarar sig i timmar i luftburna aerosoler och i flera dagar på olika ytor.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Astrazeneca tappar forskningschef
Briggs Morrison går vidare till nya uppgifter.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
9 steps to perfect partnering
Rigorous planning and a focus on your business plan is essential for successful partnering, accoring to Camilla Huse Bondeson at Conlega. Follow her 9 steps to ...
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Granskar Mylan-budet
Investeringsbolaget VEB undersöker om budet på svenska Meda bryter mot lagen.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Tio minuters trädgårdsarbete räcker
Så lite som tio minuters motion per vecka ser ut att minska risken för hjärtdöd, enligt en kinesisk observationsstudie.
-
Sanofi sparkar sin vd
Den franska läkemedelskoncernen gör sig av med koncernchefen Christopher A Viebacher.
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
BREAKING